Gujarat Kidney and Super Speciality Limited IPO
Gujarat Kidney and Super Speciality Limited was a mainboard IPO in the Hospital sector, offered at ₹108–₹114 per share to raise ₹251 crore. The issue was subscribed 5.21× overall (QIBs 1.06×, NIIs 5.73×, retail 19.04×). It listed on 30 Dec 2025 at ₹120 and closed its first day at ₹105, a listing loss of -8.3% versus the ₹114 issue price. It now trades around ₹163 (+43.2% versus the issue price).
Frequently asked questions
- How many times was the Gujarat Kidney and Super Speciality Limited IPO subscribed?
- The Gujarat Kidney and Super Speciality Limited IPO was subscribed 5.21× overall — 1.06× in the QIB category, 5.73× among non-institutional investors, 19.04× in retail.
- What were the Gujarat Kidney and Super Speciality Limited IPO listing gains?
- Gujarat Kidney and Super Speciality Limited listed on 30 Dec 2025 at ₹120, closing its first day at ₹105 — a listing loss of -8.3% versus the ₹114 issue price.
- What were the retail allotment odds for the Gujarat Kidney and Super Speciality Limited IPO?
- Retail was subscribed 19.04×, so a single-lot application had roughly a 5.3% chance of allotment (about 1 in 19), and allotment was finalised on 26 Dec 2025.
- What was the price band and lot size of the Gujarat Kidney and Super Speciality Limited IPO?
- The price band was ₹108–₹114 per share, with a minimum lot of 128 shares (₹14,592 at the upper band).
- Who were the registrar and lead manager for the Gujarat Kidney and Super Speciality Limited IPO?
- MUFG Intime India Private Limited was the registrar, and Nirbhay Capital Services was the book-running lead manager.